Neoadjuvant Chemoradiotherapy Best Restricted to High-Risk Rectal Cancer Patients Neoadjuvant Chemoradiotherapy Best Restricted to High-Risk Rectal Cancer Patients
Because neoadjuvant chemoradiotherapy in patients with rectal cancer carries a high risk of adverse effects, careful selection is needed to avoid possibly harmful treatment, according to new research.Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Hematology | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Pathology | Rectal Cancers